LEP and Familial prostate cancer: Here we systematically review the epidemiological evidence on associations of circulating adiponectin and leptin with overall and aggressive (higher grade and/or more advanced stage) prostate cancer and combine study-specific effect estimates in a dose–response meta-analysis.